Found: 12
Select item for more details and to access through your institution.
Web-based clinical assessments for Parkinson's disease: Reliable and feasible.
- Published in:
- Movement Disorders, 2012, v. 27, n. 11, p. 1466, doi. 10.1002/mds.25121
- By:
- Publication type:
- Article
Molecular Advances in the Treatment of Advanced Gastrointestinal Stromal Tumor.
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 671, doi. 10.1093/oncolo/oyad167
- By:
- Publication type:
- Article
Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1263, doi. 10.1002/onco.13801
- By:
- Publication type:
- Article
Novel Methods and Technologies for 21st-Century Clinical Trials.
- Published in:
- JAMA Neurology, 2015, v. 72, n. 5, p. 582, doi. 10.1001/jamaneurol.2014.4524
- By:
- Publication type:
- Article
Randomized Controlled Clinical Trial of "Virtual House Calls" for Parkinson Disease.
- Published in:
- JAMA Neurology, 2013, v. 70, n. 5, p. 565, doi. 10.1001/jamaneurol.2013.123
- By:
- Publication type:
- Article
Impact of Alternative Medical Device Approval Processes on Costs and Health.
- Published in:
- CTS: Clinical & Translational Science, 2014, v. 7, n. 5, p. 368, doi. 10.1111/cts.12199
- By:
- Publication type:
- Article
Incidence of bleeding events in patients on concomitant tyrosine kinase inhibitors and selective serotonin reuptake inhibitors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1119, doi. 10.1177/10781552221098044
- By:
- Publication type:
- Article
Setting Intentions.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 4, p. 287, doi. 10.1001/jama.2023.26823
- By:
- Publication type:
- Article
Secondary histiocytic sarcoma with BRAF<sup>V600E</sup> mutation responsive to MAPK‐targeted therapy presenting with recurrence with mTOR mutation responsive to mTOR‐targeted therapy.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 10, p. 1, doi. 10.1002/pbc.29166
- By:
- Publication type:
- Article
Secondary histiocytic sarcoma with BRAF<sup>V600E</sup> mutation responsive to MAPK-targeted therapy presenting with recurrence with mTOR mutation responsive to mTOR-targeted therapy.
- Published in:
- 2021
- By:
- Publication type:
- letter
Secondary histiocytic sarcoma with BRAF<sup>V600E</sup> mutation after T-cell acute lymphoblastic leukemia in a very young child with dramatic response to dabrafenib and trametinib.
- Published in:
- 2020
- By:
- Publication type:
- case study
Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia.
- Published in:
- Clinical Case Reports, 2021, v. 9, n. 5, p. 1, doi. 10.1002/ccr3.4115
- By:
- Publication type:
- Article